UPDATED: Veea Signs Term Sheet To Combine With NovaGen; GeoNova Capital, As Cornerstone Investor, Has Signed A Term Sheet To Provide An Initial $10M Investment In The Combined Company; Combined Company Is ~$750M
Veea Inc. (NASDAQ:VEEA), a provider of AI-powered, cybersecure edge infrastructure, and NovaGen Group B.V., a personalized regenerative medicine and longevity company, today announced they have signed a term sheet to
Veea is combining with NovaGen, a longevity medicine company, in a planned merger. An investor is putting in $10 million to help, which shows someone believes in the combined business.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.